Your browser doesn't support javascript.
loading
TAT-W61 peptide attenuates neuronal injury through blocking the binding of S100b to the V-domain of Rage during ischemic stroke.
Liang, Jia; Li, Hui; Liu, Chang-Dong; Zhou, Xiao-Yan; Fu, Yan-Yan; Ma, Xiang-Yu; Liu, Dan; Chen, Yu-Ling; Feng, Qian; Zhang, Zhen; Wen, Xiang-Ru; Zhu, Guang; Wang, Nan; Song, Yuan-Jian.
Affiliation
  • Liang J; Xuzhou Engineering Research Center of Medical Genetics and Transformation, Key Laboratory of Genetic Foundation and Clinical Application, Department of Genetics, Xuzhou Medical University, Xuzhou, 221004, China.
  • Li H; Department of Pathology, Xuzhou Medical University, Xuzhou, 221004, China.
  • Liu CD; Xuzhou Engineering Research Center of Medical Genetics and Transformation, Key Laboratory of Genetic Foundation and Clinical Application, Department of Genetics, Xuzhou Medical University, Xuzhou, 221004, China.
  • Zhou XY; State Key Laboratory of Molecular Neuroscience, The Hong Kong University of Science and Technology, Clear Water Bay, Kowloon, Hong Kong SAR, 00000, China.
  • Fu YY; Xuzhou Engineering Research Center of Medical Genetics and Transformation, Key Laboratory of Genetic Foundation and Clinical Application, Department of Genetics, Xuzhou Medical University, Xuzhou, 221004, China.
  • Ma XY; Department of Cell Biology and Neurobiology, Xuzhou Medical University, Xuzhou, 221004, China.
  • Liu D; Xuzhou Engineering Research Center of Medical Genetics and Transformation, Key Laboratory of Genetic Foundation and Clinical Application, Department of Genetics, Xuzhou Medical University, Xuzhou, 221004, China.
  • Chen YL; Xuzhou Engineering Research Center of Medical Genetics and Transformation, Key Laboratory of Genetic Foundation and Clinical Application, Department of Genetics, Xuzhou Medical University, Xuzhou, 221004, China.
  • Feng Q; Xuzhou Engineering Research Center of Medical Genetics and Transformation, Key Laboratory of Genetic Foundation and Clinical Application, Department of Genetics, Xuzhou Medical University, Xuzhou, 221004, China.
  • Zhang Z; Xuzhou Engineering Research Center of Medical Genetics and Transformation, Key Laboratory of Genetic Foundation and Clinical Application, Department of Genetics, Xuzhou Medical University, Xuzhou, 221004, China.
  • Wen XR; Xuzhou Engineering Research Center of Medical Genetics and Transformation, Key Laboratory of Genetic Foundation and Clinical Application, Department of Genetics, Xuzhou Medical University, Xuzhou, 221004, China.
  • Zhu G; Department of Chemistry, School of Pharmacy, Xuzhou Medical University, Xuzhou, 221004, China.
  • Wang N; State Key Laboratory of Molecular Neuroscience, The Hong Kong University of Science and Technology, Clear Water Bay, Kowloon, Hong Kong SAR, 00000, China.
  • Song YJ; Research Center for Biochemistry and Molecular Biology, Jiangsu Key Laboratory of Brain Disease Bioinformation, Xuzhou 221004, Jiangsu, China. wangnan@xzhmu.edu.cn.
J Mol Med (Berl) ; 102(2): 231-245, 2024 Feb.
Article in En | MEDLINE | ID: mdl-38051341
Subject(s)
Key words
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Health context: 6_ODS3_enfermedades_notrasmisibles Database: MEDLINE Main subject: Ischemic Stroke Limits: Animals Language: En Journal: J Mol Med (Berl) Year: 2024 Document type: Article
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Health context: 6_ODS3_enfermedades_notrasmisibles Database: MEDLINE Main subject: Ischemic Stroke Limits: Animals Language: En Journal: J Mol Med (Berl) Year: 2024 Document type: Article